You are here

Joshua Boger, Founder and Former CEO of Vertex Pharmaceuticals, Speaks on Biotechnology, April 11

Newsroom

Joshua Boger, Founder and Former CEO of Vertex Pharmaceuticals, Speaks on Biotechnology, April 11

Joshua Boger, founder and former CEO of Vertex Pharmaceuticals, will speak at Bentley on Monday, April 11, at 3:30 p.m.in Wilder Pavilion. Following his address, "Biotechnology in the 21st Century," a reception will be held.

Boger retired as Vertex's CEO in May 2009, after over 20 years with the company, and continues to serve on the Vertex Board.  Prior to founding Vertex in 1989, he served as Senior Director of Basic Chemistry at Merck Sharp & Dohme Research Laboratories in Rahway, N.J., where he headed both the departments of Biophysical Chemistry and Medicinal Chemistry of Immunology & Inflammation. During his ten years at Merck, he developed an international reputation as a leader in the application of computer modeling to the chemistry of drug design and was a pioneer in the use of structure-based rational drug design as the basis for drug discovery programs.

His postdoctoral research in molecular recognition was performed in the laboratories of the Nobel-prize winning chemist, Jean-Marie Lehn in Strasbourg, France.  He is the author of more than 50 scientific publications, holds 32 issued U.S. patents in pharmaceutical discovery and development, and has lectured widely in the United States, in Europe and in Asia on various aspects of drug discovery and development.  He was named one of forty "Technology Pioneers" worldwide for the 2003 World Economic Forum in Davos, Switzerland.

For more information, e-mail Fred Ledley.

BENTLEY UNIVERSITY is one of the nation’s leading business schools, dedicated to preparing a new kind of business leader – one with the deep technical skills, broad global perspective, and high ethical standards required to make a difference in an ever-changing world. Our rich, diverse arts and sciences program, combined with an advanced business curriculum, prepares informed professionals who make an impact in their chosen fields. Located on a classic New England campus minutes from Boston, Bentley is a dynamic community of leaders, scholars and creative thinkers. The Graduate School emphasizes the impact of technology on business practice, in offerings that include MBA and Master of Science programs, PhD programs in accountancy and in business, and customized executive education programs. The university enrolls approximately 4,100 full-time undergraduate, 140 adult part-time undergraduate, 1,430 graduate, and 43 doctoral students. Bentley is accredited by the New England Association of Schools and Colleges; AACSB International – The Association to Advance Collegiate Schools of Business; and the European Quality Improvement System, which benchmarks quality in management and business education. For more information, please visit www.bentley.edu

FEATURE STORY

Careers
by Bentley University
0

By 2025, millennials will make up 75 percent of the workforce. Is your company ready for them? Download the ebook.

AROUND THE WEB

Gallup, Inc., Gallup.Com | November 20, 2014
Millionaire Corner | November 19, 2014
Politics, Political News | November 13, 2014